Retailers Continue to Wrap Their Minds Around CBD

CSP forum on medicinal remedies keeps discussion moving forward
Photograph: Shutterstock

CHARLOTTE, N.C. While retailers remain cautious about selling hemp-based products, experts at CSP’s CBD & Convenience Retail conference shed more light on cannabidiol (CBD) and the growing category of medicinal remedies.

About 80 retailers and suppliers attended the event, held Oct. 28-30 in Charlotte, N.C., which featured topics ranging from legal issues to product quality. Talking about how the U.S. Food and Drug Administration (FDA) would want to handle CBD products, speaker Jonathan Havens of Saul Ewing Arnstein & Lehr LLP, Baltimore, said, “The FDA doesn’t want to regulate CBD, and if they do, it’s going to take years.”

The FDA would prefer the industry regulate itself, keeping in mind what’s best for the consumer, Havens said.

Meanwhile, the topic of hemp and CBDs continued to make news. Here’s a compilation of the most recent stories …

Agency would prefer industry regulates itself, CSP forum speaker says

Despite regulatory uncertainty, industry continues expansion

Growers must overcome hurdles to gain profitability

Policies reportedly touch on potency, quality control

About 60% of people seek relief from anxiety, but does it work?

More retailers exploring potential of medicinal remedy

Speakers explore potential of adding ingredient to consumer products

Want breaking news at your fingertips?

Get today’s need-to-know convenience industry intelligence. Sign up to receive texts from CSP on news and insights that matter to your brand.

Related Content


More from our partners